Tabriz University of Medical Sciences Advanced Pharmaceutical Bulletin 2228-5881 2 1 2012 06 30 Hypothesis: Silver Nanoparticles as an Adjuvant for Cancertherapy 133 133 10.5681/apb.2012.020 EN Ramin Mohammadzadeh Journal Article 10.5681/apb.2012.020 2012 01 09 Cytotoxic agents are a main part of therapeutic process against the observed tumors, which lead to some unwished damages, due to drug uptake by normal body cells causing various tissue/organ failures associated with formal administration manners. But nowadays the risk is reduced by new target therapy techniques, of which the observed physical nature of micelles and nanosilver particles, governing their special behavior, could help using micelle-coated silver nanoparticles as a novel adjuvant for cancer target therapy.